Diagnoses and Prevalence of HIV Infection Among Hispanics or Latinos — United States, 2008–2013
Kristen Mahle Gray, MPH1; Eduardo E Valverde, DrPH1; Tian Tang, MS2; Azfar-e-Alam Siddiqi, MD, PhD1; H. Irene Hall, PhD1
Hispanics or Latinos* represent about 17% of the total U.S. population and are disproportionately affected by human immunodeficiency virus (HIV) infection in the United States (1,2). In 2013, the rate of HIV diagnosis among Hispanics or Latinos (18.7) was nearly three times that of non-Hispanic whites (6.6) (1). To better characterize HIV infection among Hispanics or Latinos aged =13 years in the United States, CDC analyzed data from the National HIV Surveillance System (NHSS). During 2008–2013, the rate of diagnoses of HIV infection among adult and adolescent Hispanics or Latinos decreased from 28.3 per 100,000 population in 2008 to 24.3 in 2013 (estimated annual percentage change [EAPC] = -3.6); however, the number of diagnoses among males with infection attributed to male-to-male sexual contact increased 16%, from 6,141 in 2008 to 7,098 in 2013 (EAPC = 3.0). In 2013, the rate of diagnosis of HIV infection among males (41.3) was six times the rate among females (6.8). During 2008–2013, behavioral risk factors for HIV infection among Hispanics or Latino differed among males and females and by place of birth. Among Hispanic or Latino males born in Puerto Rico, the proportion of HIV infections attributed to injection drug use (24.9%) was greater than among those born elsewhere. Among HIV-infected Hispanic or Latino females, those born in the United States (21.2%) and Puerto Rico (20.5%) had a greater proportion of HIV infections attributed to injection drug use than those born elsewhere. Additional interventions and public health strategies to further decrease the rates of HIV among the Hispanic or Latino population are needed.
Data from NHSS reported to CDC from the early 1980s through December 2014 were used to determine the numbers and rates of diagnosis of HIV infection among Hispanics or Latinos aged =13 years (adults and adolescents) during 2008–2013 and prevalence in 2012, by selected characteristics. The numerator for each rate was the estimated number of diagnoses of HIV infection by diagnosis year. Appropriate subpopulations from the census or postcensus data from the U.S. Census Bureau were used for the denominator (2). Rates of infection by HIV transmission categories (male-to-male sexual contact, injection drug use, male-to-male sexual contact and injection drug use, heterosexual contact, or other) could not be calculated because the U.S. Census does not collect the data needed for the denominators. In calculating the EAPC in rates, populations were treated as actual populations and not samples, because the standard deviation of these populations was not available from the U.S. Census. Data from NHSS were also used to ascertain 1) HIV diagnoses in 2013 among Hispanics or Latinos by place of birth and transmission category, and 2) the numbers and rates of Hispanics or Latinos living with diagnosed HIV infection at year-end 2012 by area of residence at diagnosis. Birthplace information was available for 83.7% of Hispanics or Latinos in this analysis. Data were statistically adjusted for reporting delays and missing HIV transmission categories (3).
During 2008–2013, a total of 276,633 adults and adolescents received a diagnosis of HIV infection in the 50 states and the District of Columbia. Of these, 57,406 (20.8%) were Hispanics or Latinos. A decline was observed in the rates of diagnosis per 100,000 population among Hispanic or Latino adults and adolescents, from 28.3 per 100,000 population in 2008 to 24.3 in 2013 (EAPC = -3.6) (Table 1). During 2008–2013, the HIV diagnosis rate decreased among Hispanic or Latino males from 45.0 per 100,000 to 41.3 (EAPC = -2.0) and among females from 10.1 per 100,000 to 6.8 (EAPC = -9.6). The rates remained stable or decreased among all age groups, with the largest decline among persons aged 35–44 years (39.6 per 100,000 to 29.5 [EAPC = -6.8]). Among Hispanic or Latino males with infection attributed to male-to-male sexual contact, the number of HIV diagnoses increased 16% (EAPC = 3.0), whereas diagnoses decreased in other transmission categories (Figure). Among Hispanic or Latino females, the estimated number of HIV diagnoses decreased in persons with infection attributed to injection drug use or heterosexual contact. The largest declines in males (EAPC = -8.6) and females (EAPC = -11.8) were observed among those with infection attributed to injection drug use (Table 1).
In 2013, the HIV diagnosis rate per 100,000 population among males (41.3) was more than six times the rate among females (6.8). By age group, the highest rate of HIV diagnosis (40.1) among Hispanics or Latinos occurred among persons aged 25–34 years. By transmission category, the largest number of HIV diagnoses occurred among males with infection attributed to male-to-male sexual contact (7,098 [82.8%]), and among females with infection attributed to heterosexual contact (1,194 [87.2%]) (Table 1). The estimated rate of diagnosis for 2013 ranged from 2.3 in Idaho to 90.1 in the District of Columbia (Table 2).
HIV transmission category among Hispanics or Latinos varied by place of birth (Table 3). Infection attributed to male-to-male sexual contact accounted for the majority of infection transmissions among males, irrespective of place of birth, ranging from a low of 53.6% among persons born in Puerto Rico to a high of 86.4% among persons born in South America. Hispanic or Latino males born in Puerto Rico had a higher proportion of HIV infections attributed to injection drug use (24.9%) than those born elsewhere, whereas Hispanic or Latino females born in the United States (21.2%) and Puerto Rico (20.5%) had a higher proportion of HIV infections attributed to injection drug use than those born elsewhere. A smaller proportion of Hispanic or Latino males born in the United States (6.6%) had infection attributed to heterosexual contact compared with male Hispanics or Latinos born elsewhere. A smaller proportion of Hispanic or Latino females born in the United States (78.2%) and Puerto Rico (79.2%) had infection attributed to heterosexual contact compared with female Hispanics or Latinos born elsewhere.
At year-end 2012, an estimated 911,602 adults and adolescents were living with diagnosed HIV infection, and of these, 183,300 (20.1%) were Hispanics or Latinos (Table 2); the rate of persons living with HIV infection among Hispanics or Latinos was estimated at 458.8 per 100,000 population, and the estimated HIV prevalence ranged from 73.6 per 100,000 population in Montana to 1,947.5 in the District of Columbia (Table 2).
Discussion
During 2008–2013, overall diagnoses of HIV infection among adult and adolescent Hispanics or Latinos decreased in the United States. However, decreases have not occurred uniformly because diagnoses of HIV infection among men who have sex with men increased. This increase might have resulted from increased incidence of HIV infection, an increase in HIV testing among Hispanic or Latino men who have sex with men, or a combination of both of these factors (4).
An estimated 43% of Hispanics or Latinos who received an HIV diagnosis were not born in the United States or Puerto Rico (a U.S. territory), and among these Hispanic or Latino immigrants, 66% were men who have sex with men. The large proportion of HIV diagnoses in the United States among Hispanics or Latinos who are immigrants is important to consider when developing HIV prevention interventions, given that approximately 40% of Hispanic or Latino immigrants do not speak English well or at all (5) and because certain socioeconomic factors, such as limited access to health care, lack of health insurance, and poverty, might be at play (6).
Findings from this report also confirm earlier findings that Hispanics or Latinos are not a homogenous group, and risk factors differ by place of birth (7,8). The majority of males born in Puerto Rico with infection diagnosed during 2008–2013 had infections attributed to male-to-male sexual contact, highlighting a change in HIV transmission patterns, which until recently indicated that the most common HIV transmission category among men in Puerto Rico was injection drug use (9). Still, a much larger proportion of Hispanic or Latino males born in Puerto Rico reported infection attributed to injection drug use compared with Hispanic or Latino males born elsewhere. HIV care providers working in communities where Puerto Ricans reside should be mindful of a recent report indicating that levels of linkage to care, retention in care, prescription of antiretroviral therapy, and viral suppression were lower among Hispanics or Latinos with HIV infection attributed to injection drug use than among those with infection attributed to male-to-male sexual contact and heterosexual contact (10).
The findings in this report are subject to at least two limitations. First, misclassification of Hispanics or Latinos as members of other races/ethnicities might have resulted in underestimation of the number of Hispanics or Latinos overall and of Hispanic or Latino subgroups. Second, birthplace information was missing for 16% of Hispanics or Latinos in this analysis. Depending on the distribution of birthplaces for persons with missing information, transmission category prevalence for certain subgroups might have been larger or smaller.
The disproportionate rate of HIV infection among Hispanics or Latinos and the disparities found within this population indicate that much work still needs to be done to reach Hispanics or Latinos at high risk for acquiring or transmitting HIV infection. CDC and its partners are pursuing a high-impact prevention approach to maximize the effectiveness of current HIV prevention methods. Example activities include providing technical assistance to health departments and community-based organizations to deliver effective prevention interventions to Hispanics or Latinos, and supporting testing projects and campaigns that focus on Hispanics or Latinos, such as Reasons, which encourages HIV testing among Hispanic or Latino men who have sex with men. CDC funds health departments across the United States and its territories for core HIV prevention activities, including activities for Hispanics or Latinos, and supports projects to optimize care outcomes, such as the Care and Prevention in the United States demonstration project, which promotes increased testing and linkage to, retention in, and reengagement in care for racial and ethnic minorities living with HIV (6).
1Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC; 2ICF International, Atlanta, Georgia.
Corresponding author: Kristen Mahle Gray, kgray1@cdc.gov, 404-639-2050.
Harrison KM, Kajese T, Hall HI, Song R. Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep 2008;123:618–27.
Johnson AS, Hall HI, Hu X, Lansky A, Holtgrave DR, Mermin J. Trends in diagnoses of HIV infection in the United States, 2002–2011. JAMA 2014;312:432–4.
Espinoza L, Hall HI, Hu X. Diagnoses of HIV infection among Hispanics/Latinos in 40 states and Puerto Rico, 2006–2009. J Acquir Immune Defic Syndr 2012;60:205–13.
Hispanics or Latinos represent about 17% of the total U.S. population and are disproportionately affected by human immunodeficiency virus (HIV) infection in the United States. In 2013, the rate of HIV diagnosis among Hispanics or Latinos (18.7 per 100,000) was nearly three times that of non-Hispanic whites (6.6).
What is added by this report?
During 2008–2013, the overall rate of the diagnoses of HIV infection among adult and adolescent Hispanics or Latinos decreased (from 28.3 per 100,000 in 2008 to 24.3 in 2013; estimated annual percentage change [EAPC] = -3.6); however, diagnoses of HIV infection among males with infection attributed to male-to-male sexual contact increased (EAPC = 3.0).
What are the implications for public health practice?
The higher rate of HIV infection among Hispanics or Latinos indicates that much work still needs to be done to reach Hispanics or Latinos at high risk for acquiring or transmitting HIV infection. Targeted strategies for Hispanic or Latino subpopulations, such as men who have sex with men and persons who inject drugs, present prevention challenges and warrant expanded efforts.
TABLE 1. Diagnoses of HIV infection* among adult and adolescent Hispanics or Latinos, by selected characteristics — United States, 2008–2013
Characteristic
2008
2009
2010
2011
2012
2013
EAPC§
p-value
95% CI
No.
Est. no.†
Rate
No.
Est. no.†
Rate
No.
Est. no.†
Rate
No.
Est. no.†
Rate
No.
Est. no.†
Rate
No.
Est. no.†
Rate
Sex
Female
1,656
1,686
10.1
1,588
1,623
9.5
1,429
1,479
7.9
1,297
1,362
7.1
1,180
1,266
6.4
1,227
1,370
6.8
-9.6
<.0001
(-11.1 to -8.1)
Male
7,967
8,106
45.0
7,773
7,949
42.8
7,565
7,819
40.6
7,566
7,914
40.0
7,743
8,264
40.8
7,748
8,568
41.3
-2.0
<.0001
(-2.7 to -1.3)
Age group at diagnosis (yrs)
13–24
1,660
1,690
18.1
1,665
1,701
17.8
1,733
1,789
16.8
1,717
1,794
16.6
1,843
1,963
17.9
1,729
1,901
17.0
-1.0
0.16
(-2.4 to 0.4)
25–34
3,243
3,300
41.0
3,151
3,224
39.4
3,027
3,129
37.0
2,978
3,115
36.4
3,106
3,315
38.3
3,171
3,514
40.1
-1.1
0.052
(-2.1 to 0.0)
35–44
2,686
2,732
39.6
2,597
2,655
37.6
2,340
2,419
33.0
2,234
2,341
31.3
2,071
2,213
28.9
2,074
2,295
29.5
-6.8
<.0001
(-8.0 to -5.6)
45–54
1,495
1,521
30.9
1,355
1,385
26.8
1,322
1,368
24.8
1,373
1,438
25.2
1,333
1,424
24.2
1,382
1,535
25.2
-4.2
<.0001
(-5.8 to -2.7)
55–64
417
425
15.1
442
453
15.1
451
466
14.3
423
441
12.8
432
465
12.8
494
551
14.4
-2.7
0.061
(-5.5 to 0.1)
=65
122
125
4.8
151
154
5.6
121
126
4.5
138
147
4.9
138
149
4.7
125
141
4.2
-2.7
0.308
(-7.6 to 2.5)
Transmission category
Male adult and adolescent
Male-to-male sexual contact
4,929
6,141
—
4,924
6,172
—
5,046
6,233
—
5,224
6,405
—
5,452
6,874
—
5,410
7,098
—
3.0
<.0001
(2.2 to 4.0)
Injection drug use
449
674
—
367
584
—
322
529
—
291
478
—
237
436
—
238
452
—
-8.6
<.001
(-12.8 to -4.2)
Male-to-male sexual contact and injection drug use
330
408
—
272
351
—
253
329
—
228
301
—
240
320
—
199
278
—
-6.6
<.01
(-11.1 to -1.9)
Heterosexual contact¶
677
872
—
640
833
—
556
722
—
551
724
—
459
624
—
518
731
—
-5.2
<.01
(-8.3 to -2.0)
Other**
1,582
11
—
1,570
9
—
1,388
6
—
1,272
7
—
1,355
9
—
1,383
10
—
-1.5
0.94
(-34.4 to 47.7)
Female adult and adolescent
Injection drug use
191
297
—
164
275
—
96
191
—
100
194
—
97
180
—
78
167
—
-11.8
<.01
(-18.2 to -4.9)
Heterosexual contact¶
883
1,384
—
820
1,342
—
762
1,283
—
635
1,162
—
577
1,076
—
580
1,194
—
-4.5
<.0001
(-6.4 to -2.4)
Other**
582
5
—
604
6
—
571
4
—
562
6
—
506
9
—
569
9
—
13.9
0.532
(-24.3 to 71.4)
Area of residence††
Urban
8,546
8,697
31.2
8,332
8,520
29.7
7,997
8,267
27.2
7,815
8,177
26.3
7,945
8,480
26.6
7,913
8,759
26.8
-3.5
<.0001
(-4.2 to -2.9)
Suburban
776
789
17.5
713
728
15.7
681
703
13.7
714
748
14.1
666
708
13.0
699
770
13.8
-5.3
<.0001
(-7.4 to -3.2)
Rural
270
273
12.0
281
286
12.2
287
295
11.7
297
308
11.9
273
291
11.0
335
368
13.6
0.5
0.754
(-2.8 to 4.0)
Unknown
31
33
—
35
38
—
29
33
—
37
44
—
39
50
—
28
41
—
—
—
—
Total§§
9,623
9,792
28.3
9,361
9,573
26.8
8,994
9,298
24.4
8,863
9,276
23.8
8,923
9,529
23.9
8,975
9,938
24.3
-3.6
<.0001
(-4.2 to -3.0)
Abbreviations: CI = confidence interval; EAPC = estimated annual percentage change; Est. = estimated; HIV = human immunodeficiency virus.
* Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
† Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information but not for incomplete reporting. Rates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
§ EAPC is based on rates with the exception of transmission category, which is based on the estimated number of diagnoses.
¶ Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
** Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
†† Urban: population of =500,000. Suburban: population of 50,000– 499,999. Rural: nonmetropolitan area.
§§ Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column might not sum to the column total.
FIGURE. Estimated number of diagnoses attributed to male-to-male sexual contact* compared with other transmission categories among Hispanic or Latino males aged =13 years, by year — United States, 2008–2013
* Male-to-male sexual contact does not include male-to-male sexual contact and injection drug use combined.
Alternate Text: The figure above is a line chart showing the estimated number of diagnoses attributed to male-to-male sexual contact compared with other transmission categories among Hispanic or Latino males aged =13 years, by year, in the United States during 2008-2013.
TABLE 2. Diagnoses of HIV infection* in 2013, and persons living with diagnosed HIV infection at year-end 2012, among adult and adolescent Hispanics or Latinos, by area of residence — United States
Area of residence
Diagnoses of HIV infection, 2013
Living with HIV infection, year-end 2012
No.
Est. no.†
Rate
No.
Est. no.†
Rate
Alabama
14
15
10.6
317
315
231.9
Alaska
2
2
6.2
65
66
196.4
Arizona
252
259
17.3
3,719
3,714
254.7
Arkansas
19
24
16.5
281
288
208.0
California
1,947
2,198
19.5
38,917
39,623
358.3
Colorado
96
98
12.0
2,282
2,279
284.8
Connecticut
92
103
25.7
3,333
3,373
865.3
Delaware
9
10
17.1
232
235
414.8
District of Columbia
42
47
90.1
967
989
1,947.5
Florida
1,266
1,299
34.4
20,518
20,478
559.8
Georgia
160
249
38.2
2,323
2,423
377.8
Hawaii
13
14
14.7
227
230
244.4
Idaho
3
3
2.3
113
113
87.6
Illinois
345
405
25.6
5,829
5,997
385.7
Indiana
49
51
17.0
730
731
253.5
Iowa
9
9
7.8
181
181
161.0
Kansas
30
32
14.0
427
427
193.8
Kentucky
19
19
19.1
328
328
333.2
Louisiana
62
64
38.1
777
774
478.1
Maine
2
2
15.6
57
58
427.3
Maryland
79
103
25.7
1,548
1,609
417.1
Massachusetts
203
297
55.5
4,397
4,623
895.9
Michigan
38
39
11.7
711
709
217.7
Minnesota
29
30
15.9
664
663
363.4
Mississippi
13
13
20.5
230
229
364.7
Missouri
19
19
11.7
615
614
381.4
Montana
1
1
4.2
17
17
73.6
Nebraska
14
14
11.1
246
246
199.2
Nevada
139
143
25.0
1,643
1,640
295.3
New Hampshire
3
3
10.8
148
149
500.8
New Jersey
395
469
35.6
9,405
9,587
745.5
New Mexico
80
82
10.7
1,244
1,242
163.8
New York
1,178
1,277
44.5
42,838
42,844
1,518.0
North Carolina
124
127
20.9
1,728
1,728
293.1
North Dakota
2
2
14.0
10
10
81.3
Ohio
60
62
22.1
997
996
369.2
Oklahoma
24
30
11.5
478
490
198.6
Oregon
46
51
14.8
691
705
210.1
Pennsylvania
179
185
31.0
4,929
4,902
850.0
Rhode Island
19
21
19.6
537
548
524.8
South Carolina
40
41
22.5
577
576
321.9
South Dakota
4
4
20.5
18
18
99.5
Tennessee
39
40
18.2
658
658
302.9
Texas
1,582
1,738
22.9
21,201
21,617
291.7
Utah
19
19
7.1
480
479
181.1
Vermont
1
1
13.5
24
24
304.1
Virginia
90
93
17.3
1,630
1,599
308.9
Washington
78
80
13.5
1,398
1,397
245.3
West Virginia
6
7
34.3
57
58
309.8
Wisconsin
38
39
15.4
663
662
268.5
Wyoming
2
2
4.9
38
38
94.1
Total§
8,975
9,938
24.3
181,443
183,300
458.8
Abbreviation: HIV = human immunodeficiency virus.
* Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
† Estimated numbers resulted from statistical adjustment that accounted for reporting delays but not for incomplete reporting. Rates are per 100,000 population.
§ Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column might not sum to the column total.
TABLE 3. Diagnoses of HIV infection* among adult and adolescent Hispanics or Latinos, by transmission category and place of birth — United States, 2008–2013
Characteristic
Central America
Cuba
Mexico
Puerto Rico
South America
No.
Est. no.§
%
No.
Est. no.§
%
No.
Est. no.§
%
No.
Est. no.§
%
No.
Est. no.§
%
Transmission category
Male adult and adolescent
Male-to-male sexual contact
1,835
2,604
74.6
1,169
1,242
82.4
5,466
6,997
80.2
812
978
53.6
1,859
2,070
86.4
Injection drug use
64
158
4.5
27
38
2.5
261
411
4.7
380
456
24.9
19
51
2.1
Male-to-male sexual contact and injection drug use
61
99
2.8
25
28
1.9
233
323
3.7
83
93
5.1
39
47
2.0
Heterosexual contact**
451
625
17.9
166
197
13.1
673
984
11.3
215
295
16.1
164
225
9.4
Other††
921
5
0.1
95
2
0.1
1,701
7
0.1
248
4
0.2
224
1
0.0
Subtotal
3,332
3,491
100.0
1,482
1,507
100.0
8,334
8,722
100.0
1,738
1,826
100.0
2,305
2,395
100.0
Female adult or adolescent
Injection drug use
14
55
6.2
4
6
5.3
33
65
5.8
99
128
20.5
10
22
7.0
Heterosexual contact**
435
828
93.5
82
109
93.5
631
1,051
93.9
300
495
79.2
184
286
92.3
Other††
394
3
0.4
29
1
1.1
405
3
0.3
191
2
0.3
103
2
0.7
Subtotal
843
886
100.0
115
117
100.0
1,069
1,119
100.0
590
624
100.0
297
310
100.0
Total§§
4,175
4,377
100.0
1,597
1,624
100.0
9,403
9,840
100.0
2,328
2,450
100.0
2,602
2,704
100.0
TABLE 3. (Continued) Diagnoses of HIV infection* among adult and adolescent Hispanics or Latinos, by transmission category and place of birth — United States, 2008–2013
Characteristic
United States
Other†
Unknown¶
Total
No.
Est. no.§
%
No.
Est. no.§
%
No.
Est. no.§
%
No.
Est. no.§¶
%
Transmission category
Male adult and adolescent
Male-to-male sexual contact
14,623
17,345
81.6
748
977
70.8
4,473
6,709
83.5
30,985
38,923
80.1
Injection drug use
905
1,404
6.6
28
95
6.9
220
541
6.7
1,904
3,154
6.5
Male-to-male sexual contact and injection drug use
887
1,089
5.1
37
48
3.5
157
260
3.2
1,522
1,987
4.1
Heterosexual contact**
1,189
1,402
6.6
167
258
18.7
376
520
6.5
3,401
4,506
9.3
Other††
2,668
26
0.1
341
2
0.2
2,352
5
0.1
8,550
52
0.1
Subtotal
20,272
21,266
100.0
1,321
1,380
100.0
7,578
8,035
100.0
46,362
48,620
100.0
Female adult or adolescent
Injection drug use
497
795
21.2
11
40
6.2
58
194
14.6
726
1,305
14.8
Heterosexual contact**
1,850
2,938
78.2
314
598
93.6
461
1,137
85.2
4,257
7,442
84.7
Other††
1,253
23
0.6
282
1
0.1
737
3
0.3
3,394
39
0.4
Subtotal
3,600
3,757
100.0
607
639
100.0
1,256
1,334
100.0
8,377
8,786
100.0
Total§§
23,872
25,022
100.0
1,928
2,019
100.0
8,834
9,369
100.0
54,739
57,406
100.0
Abbreviations: Est. = estimated; HIV = human immunodeficiency virus.
* Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
† Places of birth other than those specified.
§ Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information but not for incomplete reporting.
¶ Entries include persons whose place of birth is not among those listed and persons whose place of birth is unknown.
** Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
†† Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
§§ Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column might not sum to the column total.